Pharmafile Logo
Pharmafocus logo
Advanced Search
gsk_rd_harlow

GSK acquires oncology firm Tesaro for $5.1 billion

January 23, 2019
Research and Development Cancer, GSK, Tesaro, oncology, ovarian cancer

British multinational GlaxoSmithKline (GSK) have acquired US oncology firm Tesaro for $5.1 billion (£4 billion). Tesaro, a Massachusetts-based clinical stage …

News

NICE recommend digital CBT for young people with mild depression

January 23, 2019
Research and Development CBT, Digital CBT, NHS, psychology, psychotherapy

Britain’s cost effectiveness body NICE has recommended digital Cognitive Behavioural Therapy (CBT) for children with mild depression as a first …

News
amgen_hq

Amgen’s Blincyto secures expanded indication in Europe for acute lymphoblastic leukaemia

January 23, 2019
Research and Development, Sales and Marketing Ammgen, Cancer, Europe, European Commission, blincyto, leukaemia, pharma

The European Commission has chosen to expand the authorised indication for Amgen’s Blincyto (blinatumomab) in the region, it has emerged, …

News

Including prices on TV ads only works when the price is listed alone

January 23, 2019
Research and Development Trump, USA, pharma, pricing

Requiring pharmaceutical companies to publish the price of their drugs on adverts on TV, would probably not help to control …

News
samsung

FDA approves third Herceptin biosimilar with Samsung Bioepis’ Ontruzant

January 22, 2019
Manufacturing and Production, Sales and Marketing FDA, Herceptin, Samsung Bioepis, biosimilar, pharma

Samsung Bioepis’ has announced that the FDA has chosen to approve Ontruzant (trastuzumab-dttb), its biosimilar version of Roche’s Herceptin (trastuzumab), …

News
bi_german_building_at_night

Boehringer expands manufacturing facility in Shanghai

January 22, 2019
Manufacturing and Production Boehringer Ingelheim, China, Shanghai, facilities, manufacturing, pharma

German firm Boehringer Ingelheim has expanded the capacity of its commercial manufacturing site for biologics in Shanghai, China. The expansion …

News

Scientist who genetically modified babies faces punishment after acting illegally, Chinese authorities confirm

January 22, 2019
Manufacturing and Production China, He Jiankui, crispr, ethics, gene editing

Chinese state media have confirmed that He Jiankui, the scientist who claimed to have genetically modified babies to prevent them …

News
vertex-headquarters

Vertex’s Orkambi can be used in even younger cystic fibrosis patients, says European Commission

January 22, 2019
Manufacturing and Production, Sales and Marketing Orkambi, Vertex, cystic fibrosis, pharma

Vertex has announced that the European Commission has decided to approve a label extension in the region for Orkambi (lumacaftor/ivacaftor) …

News
abbvie_0

AbbVie’s case against the NHS thrown out of court

January 22, 2019
Manufacturing and Production AbbVie, HCV, NHS, health, hepatitis C, public health

A judge has thrown US multinational AbbVie’s case against NHS England’s hepatitis C procurement process, out of court. Mr Justice …

News
mesothelioma

Pushing for progress in mesothelioma

January 21, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, mesothelioma, pharma

Mesothelioma.net reviews the wide array of latest advances in treatment and care for patients affected by the challenging cancer as …

Feature

Just 10% of those harmed in clinical trials in India receive compensation

January 21, 2019
Sales and Marketing India, WHO, clinical trials, compensation, health

Clinical trials have led to nearly 5,000 deaths in India since 2005, while just a fraction of those affected have …

News
lilly_building_with_american_flag_web

Lilly’s Lartruvo/chemo combo surprises with Phase 3 failure in soft tissue carcinoma

January 21, 2019
Research and Development, Sales and Marketing Cancer, Eli Lilly, carcinoma, chemotherapy, pharma, trial failure

Eli Lilly has reluctantly pulled back the curtain on new Phase 3 data for its platelet-derived growth factor receptor alpha …

News
celgene_1_02

Celgene signs deals with two Massachusetts-based biotechs

January 21, 2019
Sales and Marketing Celgene, Kyn, Obsidian, cell therapy, immuno oncology, immuno-oncology

New Jersey-based biotechnology firm Celgene has signed deals with two Massachusetts-based biotechs: immuno-oncology specialist Kyn therapeutics and cell therapy firm …

News

Philip Hampton to step down from chairman role at GSK

January 21, 2019
Sales and Marketing Chairman, GSK, GlaxoSmithKline, appointment, philip hampton

Sir Philip Hampton is stepping down from his role as non-executive chairman of British multinational GlaxoSmithKline. The resignation comes just …

News
imp_pologne2

NICE recommends Pierre Fabre’s Braftovi in BRAF V600-mutated advanced melanoma

January 21, 2019
Sales and Marketing Braftovi, Cancer, NICE, Pierre Fabre, UK, melanoma, pharma

Braftovi (encorafenib), a BRAF kinase inhibitor developed by Pierre Fabre, has been awarded approval in combination with Mektovi (binimetinib) by …

News
sun-pharma-759

Sun Pharma’s shares hit six-year low after further whistleblower allegations emerge

January 18, 2019
Medical Communications India, Sun Pharma, pharma

Sun Pharma has seen its shares fall by 12% to an almost six-year low after it was rocked by allegations …

News
top_10_image

Top Ten most popular articles on Pharmafile.com this week!

January 18, 2019
Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Netherlands, Novo Nordisk, Roche, astra zeneca, prcing, sequiris, top 10, uk politics

Job switches were the theme of this week as AstraZeneca lost three, high levels executives to biotechs amid a restructuring …

News

Pharmacists warn of shortages in England

January 18, 2019
Medical Communications access, pharmacists, pricing, shortages

Pharmacists in England have warned that they are struggling to obtain many common generic medicines, as the number of medicines …

News
novartis_window

Canada Health approves Novartis’ CAR-T therapy Kymriah

January 18, 2019
Medical Communications CAR T, CAR-T, Canada, Cancer, Kymriah, Novartis, oncology

Health Canada has approved Novartis’ CAR-T therapy Kymriah for use in paediatric and young adult patients aged between three and …

News

Abbvie’s chronic lymphocytic leukaemia drug Venclytxo scores greenlight from NICE

January 18, 2019
Medical Communications, Sales and Marketing AbbVie, NHS, NICE, Venclyxto, leukaemia, pharma

A new recommendation from NICE means that thousands of patients in England and Wales will be able to receive Abbvie’s …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026